Squarepoint’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-253,193
Closed -$33.4M 5309
2025
Q1
$33.4M Buy
253,193
+103,017
+69% +$12.8M 0.08% 474
2024
Q4
$12.5M Sell
150,176
-167,578
-53% -$13.8M 0.03% 1023
2024
Q3
$23.3M Buy
317,754
+56,121
+21% +$4.22M 0.08% 530
2024
Q2
$17.9M Buy
261,633
+137,432
+111% +$9.53M 0.07% 638
2024
Q1
$8.59M Buy
124,201
+83,072
+202% +$5.71M 0.04% 1096
2023
Q4
$2.95M Sell
41,129
-43,065
-51% -$2.48M 0.01% 1745
2023
Q3
$4.39M Buy
+84,194
New +$4.9M 0.02% 1262
2023
Q2
Sell
-26,260
Closed -$1.42M 4158
2023
Q1
$1.42M Buy
+26,260
New +$1.27M 0.01% 1652
2022
Q4
Sell
-17,410
Closed -$810K 3731
2022
Q3
$810K Buy
+17,410
New +$909K 0.01% 1903
2022
Q1
Sell
-5,815
Closed -$304K 3686
2021
Q4
$304K Buy
+5,815
New +$244K ﹤0.01% 2449
2021
Q3
Sell
-8,198
Closed -$335K 3556
2021
Q2
$335K Buy
+8,198
New +$303K ﹤0.01% 2449
2021
Q1
Sell
-10,728
Closed -$341K 3728
2020
Q4
$341K Sell
10,728
-33,746
-76% -$887K ﹤0.01% 2118
2020
Q3
$1.14M Buy
+44,474
New +$1.01M 0.02% 921
2020
Q2
Sell
-12,134
Closed -$186K 2574
2020
Q1
$186K Buy
+12,134
New +$264K 0.01% 1500
2019
Q4
Sell
-147,257
Closed -$1.1M 2887
2019
Q3
$1.1M Buy
147,257
+93,712
+175% +$899K 0.01% 1168
2019
Q2
$695K Buy
53,545
+13,976
+35% +$179K 0.01% 1472
2019
Q1
$482K Buy
39,569
+14,203
+56% +$181K 0.01% 1502
2018
Q4
$289K Buy
25,366
+799
+3% +$12.9K ﹤0.01% 1527
2018
Q3
$533K Sell
24,567
-15,899
-39% -$332K 0.01% 1270
2018
Q2
$715K Sell
40,466
-4,934
-11% -$100K 0.01% 1030
2018
Q1
$956K Buy
+45,400
New +$884K 0.02% 823
2017
Q4
Sell
-16,505
Closed -$260K 2390
2017
Q3
$260K Buy
+16,505
New +$242K 0.01% 1249
2017
Q1
Sell
-20,270
Closed -$306K 1965
2016
Q4
$306K Buy
20,270
+9,407
+87% +$133K 0.01% 1145
2016
Q3
$166K Buy
+10,863
New +$439K 0.01% 918
2016
Q1
Sell
-7,000
Closed -$377K 1491
2015
Q4
$377K Buy
+7,000
New +$353K 0.04% 691

Other funds holding ITCI